Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Chronic migraine (CM) is a prevalent and devastating disorder with limited therapeutic
options. This study explored the efficacy of 10 mg/day flunarizine for CM prophylaxis as
compared with 50 mg/day topiramate.